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Background: Although an independent association between hypothyroidism and coronary 
artery disease has been demonstrated, few studies have examined the association between hypo-
thyroidism and peripheral arterial disease. In the current study, we test the hypothesis that there 
is an independent association between hypothyroidism and lower extremity arterial disease.
Methods: We retrospectively compared the prevalence of hypothyroidism in patients who had 
infra-inguinal arterial bypass surgery over a 6-year period with that of a control group of   surgical 
patients who had pure cardiac valve surgery during the same time period. Both unadjusted and 
adjusted odds ratios were calculated to estimate the association between hypothyroidism and 
lower extremity arterial disease.
Results: A total of 614 cases and 529 control subjects had surgery during the study period. 
When comparing all subjects, there was no association between hypothyroidism and lower 
extremity arterial disease (unadjusted odds ratio 0.88; 95% confidence intervals [CI]: 0.61–1.28). 
However, gender was found to be a significant effect modifier (P , 0.001), and gender-stratified 
analyses were subsequently performed. In men, there was a positive independent association 
between hypothyroidism and lower extremity arterial disease (adjusted odds ratio 2.65; 95% 
CI: 1.19–5.89), whereas in women there was a negative independent association (adjusted odds 
ratio 0.22; 95% CI: 0.11–0.46).
Conclusions: Gender is a significant effect modifier for the association between hypothyroidism 
and lower extremity arterial disease. The association is positive in men and negative in women. 
Future prospective studies that evaluate hypothyroidism as a risk factor for peripheral arterial 
disease should consider gender stratification in order to corroborate this finding.
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Introduction
Thyroid hormone has important effects on the cardiovascular system. It increases heart 
rate, stroke volume, and cardiac output. It also decreases systemic vascular resistance 
by dilating arterioles.1,2 Overt hyperthyroidism causes a hyperdynamic cardiovascular 
state, whereas overt hypothyroidism has the opposite effect. In patients with overt 
hypothyroidism, systemic vascular resistance is increased and hypertension is approxi-
mately three times more common than in those who are euthyroid.3   Hypothyroidism 
also leads to arterial stiffening and myxedema of the arterial wall over time.4 Despite 
these well-described phenomena, the long-term effect of hypothyroidism on the 
development of peripheral arterial disease is not well understood.
Both subclinical and overt hypothyroidism have been clearly linked with 
  dyslipidemia, which is a known risk factor for peripheral arterial disease.5 An Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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  independent association between overt and subclinical hypo-
thyroidism and coronary artery disease has also been demon-
strated in patients with normal   cholesterol levels, although its 
degree and clinical   significance remain controversial.6–10
The most recent publication from the Inter-Society 
  Consensus for the Management of Peripheral Arterial Disease 
does not recognize hypothyroidism as a risk factor associ-
ated with peripheral arterial disease, although some limited 
evidence suggests that there may be an association between 
the two.11 For example, a study comparing the prevalence 
of peripheral arterial disease in a group of 18 subclinically 
hypothyroid patients with that of 231 euthyroid patients found 
that the prevalence of peripheral arterial disease was signifi-
cantly higher in hypothyroid patients.12 In a second study, 
women with peripheral arterial disease were found to have 
significantly higher serum thyrotropin levels than controls.13 
Elevated thyrotropin levels were strongly correlated with 
elevated serum cholesterol levels. In two other studies using 
surrogate outcome measures, hypothyroidism was also dem-
onstrated to be associated with peripheral arterial disease.14,15 
In the first study, pulse wave Doppler analysis demonstrated 
an increased arterial stiffness that improved with levothy-
roxine therapy in hypothyroid patients. In the second study, 
hypothyroidism was associated with increased intima-media 
thickness. This finding was demonstrated to be reversible with 
levothyroxine therapy over a 6-month period. Alternatively, 
one large prospective study followed 338 patients with sub-
clinical hypothyroidism and 2392   euthyroid patients over a 
4-year period and found no increased risk of peripheral arterial 
disease during that time.16
Because conflicting evidence exists in the literature and 
few studies have examined direct clinical outcomes such as 
the need for surgical intervention, further studies are needed 
to clarify this association. In the following study, we test the 
hypothesis that hypothyroidism is independently associated 
with lower extremity arterial disease that is severe enough 
to require surgical intervention.
Methods
study design
A case-control study comparing adult patients who had lower 
extremity arterial bypass surgery with a control group of age-
matched surgical patients was performed. In both the groups, 
discharge summaries, anesthesia records, and surgical preop-
erative histories were reviewed. From these records, we specifi-
cally recorded any history of diabetes mellitus, hypertension, 
dyslipidemia, coronary artery disease, and hypothyroidism. We 
also recorded general demographic data for both groups.
study subjects
The study received approval from the Mount Sinai Hospital 
Institutional Review Board. Subjects were identified using 
procedure codes from an electronic database. All patients in 
the case group had lower extremity arterial bypass surgery 
between January 2002 and January 2008, and controls had 
isolated cardiac valve surgery during the same time period. 
Specifically, the case group included femoral-popliteal 
bypasses, femoral-tibial bypasses, and other femoral-distal 
bypasses. Both primary and repeat cases were included in 
our analyses. No subject was counted more than once, even if 
they had multiple operations during the study period, and only 
a patient’s first operation was included in the analysis. Among 
controls, we limited subjects to those who were .60 years 
of age in order to age-match the control group with the case 
group. All patients with a known history of lower extremity 
arterial disease were excluded from the control group.
Definitions
Patients were defined as hypertensive if they had a   diagnosis 
of hypertension in their preoperative history or anesthesia 
record and were receiving antihypertensive medication 
  preoperatively. Diabetes mellitus was defined as having 
the diagnosis written in either the preoperative history or 
  anesthesia record and receiving either insulin or an oral 
hypoglycemic medication preoperatively. Dyslipidemia 
was defined as having a diagnosis of elevated cholesterol 
or   triglycerides written in either the preoperative   history 
or anesthesia record and receiving lipid-lowering therapy 
preoperatively. A patient was defined as having coronary 
artery disease if they had any one of the following: cardiac 
catheterization showing stenosis that required bypass, 
  previous myocardial infarction, positive nuclear stress test, 
previous cardiac revascularization procedure, previous 
Q wave on an EKG, or if they were taking nitrates preopera-
tively for chest pain. Patients were identified as hypothyroid 
if they had a diagnosis of hypothyroidism written in their 
preoperative history or anesthesia record and had been taking 
thyroid hormone replacement preoperatively.
statistical analysis
For two group comparisons, χ2 tests were used to compare 
categorical variables, and Student’s t-tests were used for 
continuous variables. The unadjusted odds ratios were 
calculated by dividing the odds of having lower extremity 
arterial disease in the exposure group by the odds of having 
lower extremity arterial disease in the nonexposure group. 
Logistic regression analysis was performed to assess the Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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covariate-adjusted relationship between hypothyroidism and 
lower extremity arterial disease. The covariates included 
hypertension, diabetes mellitus, dyslipidemia, ischemic heart 
disease, age, and gender. Results of the logistic regression 
analysis were presented as adjusted odds ratios.
Additionally, we assessed all possible two-way interac-
tions between hypothyroidism and the previously mentioned 
covariates. For any variable shown to have a statistically sig-
nificant effect modification, we performed further stratified 
analyses, continuing to adjust for all other covariates. All 
statistical analyses were carried out using SAS software (SAS 
Institute, Inc., Cary, NC). For all analyses, P values of ,0.05 
were considered statistically significant.
Results
All subject analysis
A total of 614 cases and 529 controls met study enrollment 
criteria. As shown in Table 1, among all subjects, cases and 
controls did not differ in gender or age distribution. The 
prevalence of diabetes mellitus, hypertension, dyslipidemia, 
and ischemic heart disease was higher in cases than in con-
trols (P , 0.05). The prevalence of hypothyroidism, however, 
was not different between cases and controls (P = 0.50).
In the univariate analysis, diabetes mellitus, hypertension, 
dyslipidemia, and ischemic heart disease all had a positive 
association with lower extremity arterial disease (Table 2). 
Hypothyroidism, age, and gender had no significant associa-
tion. Logistic regression analysis was then performed using 
age, gender, diabetes mellitus, dyslipidemia, hypertension, 
and ischemic heart disease as covariates, and again no 
significant association was found between hypothyroidism 
and lower extremity arterial disease. However, a highly 
significant two-way interaction between gender and hypo-
thyroidism was detected (P , 0.001). This suggested that 
gender was an effect modifier for the association between 
hypothyroidism and lower extremity arterial disease. For 
this reason, we also performed gender-stratified analysis. 
No other variable was found to be an effect modifier for the 
relationship between hypothyroidism and lower extremity 
arterial disease (all P . 0.05).
gender-stratified analysis
After gender stratification, significant differences were still 
found between cases and controls within individual gender 
groups. For example, for both genders, the prevalence of 
diabetes mellitus, hypertension, dyslipidemia, and ischemic 
heart disease was higher in cases than in controls (Table 1). 
The prevalence of hypothyroidism was found to be higher 
in male cases than in controls, whereas the opposite was true 
in women. Male cases were older than controls, whereas the 
opposite was true in women.
In the gender-stratified univariate analysis, diabetes 
mellitus, hypertension, dyslipidemia, and ischemic heart 
disease were positively associated with lower extremity arte-
rial disease in both gender groups (Table 3). However, the 
associations between hypothyroidism and lower extremity 
arterial disease as well as age and lower extremity arterial 
disease differed by gender. In men, there was a positive asso-
ciation between hypothyroidism and lower extremity arterial 
disease, whereas in women there was a negative association. 
In men, there was a negative association between age and 
lower extremity arterial disease, whereas in women there was 
a positive association.
When logistic regression analysis was performed, we 
found a persistent positive association between hypothy-
roidism and lower extremity arterial disease in men and 
a persistent negative association in women. Compared to 
the unadjusted odds ratios, the adjusted ratios were slightly 
different in magnitude, but remained highly significant in 
both genders.
Table 1 Baseline characteristics of subjects
Variable All subjects (n = 1143) Males (n = 535) Females (n = 608)
Cases (n = 614) Controls (n = 529) Cases (n = 299) Controls (n = 236) Cases (n = 315) Controls (n = 293)
Hypothyroidism 63 (10.3%) 61 (11.5%) 44 (14.8%) 12 (5.1%)* 19 (6.0%) 49 (16.7%)*
Diabetes mellitus 388 (63.2%) 99 (18.7%)* 188 (62.9%) 36 (15.3%)* 200 (63.5%) 63 (21.5%)*
Hypertension 528 (86.0%) 317 (59.9%)* 269 (90.0)% 133 (56.4%)* 259 (82.2%) 184 (62.8%)*
Dyslipidemia 332 (54.1%) 202 (38.2%)* 163 (54.5%) 91 (38.6%)* 169 (53.7%) 111 (37.9%)*
ischemic heart  
disease
386 (62.9%) 102 (19.3%)* 171 (57.2%) 58 (24.6%)* 215 (68.3%) 44 (15.0%)*
Male gender 299 (48.7%) 236 (44.6%) – – – –
Age1 71.9 (13.1) 72.1 (7.8) 74.2 (13.2) 71.2 (7.9)* 69.8 (12.6) 72.7 (7.7)*
Notes:  1All data represent n = absolute numbers (percent of category total) except for age, where the data represent mean age (standard deviation); *P , 0.01 for 
comparison between cases and controls within each group.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Both diabetes and ischemic heart disease also remained 
strongly associated with lower extremity arterial disease in 
men and women in the multivariate analysis (Table 3). The 
association between hypertension and lower extremity arterial 
disease, however, was less strong in women (the P value for 
the two-way interaction between gender and hypertension was 
,0.01). Dyslipidemia did not show any significant associa-
tion with lower extremity arterial disease in the multivariate 
analysis in either gender. Age had a significant association 
with lower extremity arterial disease in both males and 
females, but the association differed by gender and the results 
were opposite of those seen in the univariate analysis.
Discussion
Our study was designed as a case-control study because 
it allowed us to identify a large number of patients with 
lower extremity arterial disease from an existing surgical 
database. This was more practical than following patients 
with hypothyroidism prospectively to determine the rate of 
lower extremity arterial disease over time. When identifying 
cases and controls, we used the same surgical database. An 
advantage of this design is that subjects in both groups share 
a comparable level of accuracy and quality of data. The avail-
ability of specific demographic and clinical information was 
similar for both groups, and we used consistent methodology 
in applying the definitions described in our methods.
A potential limitation of any case-control study is misclas-
sification of subjects. The result of misclassification is typi-
cally to bias toward the null hypothesis. As such, the finding 
in our study among all subjects of no statistically significant 
association between hypothyroidism and lower extremity 
arterial disease could have been a result of misclassification. 
Specifically, if a large number of controls had undiagnosed 
lower extremity arterial disease, such misclassification would 
bias our results toward the null association. However, in our 
control group, all patients had a preoperative cardiac catheter-
ization, allowing us to determine the prevalence of coronary 
artery disease in that group with a high level of accuracy. This is 
helpful in estimating the prevalence of undiagnosed peripheral 
arterial disease because previous studies have reported a high 
rate of concurrence between the two diseases (between 50% 
and 90%).17,18 In our control group, we found a prevalence of 
coronary artery disease of 19%, less than the expected rate of 
40%–60% among elderly subjects in the general population.19,20 
Therefore, we believe that it is unlikely that a high rate of 
undiagnosed lower extremity arterial disease among control 
subjects biased our results toward the null.
The differing association between hypothyroidism 
and lower extremity arterial disease in men and women is 
interesting, and to our knowledge, no prior study has dem-
onstrated such a gender-specific difference. Because our 
Table 2 Unadjusted and adjusted odds ratios of lower extremity 
arterial disease for study variables
Variable Unadjusted  
OR1 (95% CI)
Adjusted  
OR2 (95% CI)
Hypothyroidism
All 0.88 (0.61, 1.28) n/a3
  Male – 2.85 (1.31, 6.16)*
  Female – 0.26 (0.13, 0.52)*
Diabetes mellitus 7.46 (5.67, 9.80)* 5.18 (3.82, 7.03)*
Hypertension 4.11 (3.08, 5.47)* 2.35 (1.66, 3.32)*
Dyslipidemia 1.93 (1.52, 2.44)* 0.88 (0.64, 1.17)
ischemic heart disease 7.09 (5.40, 9.29)* 5.32 (3.91, 7.24)*
Age (per 10 years) 1.01 (0.91, 1.13) 0.97 (0.85, 1.11)
Male gender 1.18 (0.93, 1.49) –
Notes:  1Unadjusted  odds  ratios  were  calculated  using  the  following  method: 
OR, Odds of having lower extremity arterial disease in exposure group/Odds of 
having  lower  extremity  arterial  disease  in  nonexposure  group;  2Adjusted  odds 
ratios were obtained from a multivariate logistic regression model that included all 
variables in this table; 3For hypothyroidism, an adjusted odds ratio is listed for males 
and females separately. This is because a significant interaction between gender 
and hypothyroidism was found (P , 0.001), demonstrating the effect modification 
that gender had on the relationship between hypothyroidism and lower extremity 
arterial disease. *P , 0.05.
Abbreviations: ci, confidence intervals; OR, odds ratio
Table 3 Unadjusted and adjusted odds ratios of lower extremity arterial disease for study variables by gender
Variable Males Females
Unadjusted  
OR1 (95% CI)
Adjusted  
OR2 (95% CI)
Unadjusted  
OR1 (95% CI)
Adjusted  
OR2 (95% CI)
Hypothyroidism 3.23 (1.67, 6.28)** 2.65 (1.19, 5.89)* 0.32 (0.18, 0.56)** 0.22 (0.11, 0.46)**
Diabetes mellitus 9.41 (6.15, 14.4)** 8.04 (4.94, 13.1)** 6.35 (4.43, 9.11)** 3.99 (2.60, 6.13)**
Hypertension 6.94 (4.40, 11.0)** 4.33 (2.54, 7.39)** 2.74 (1.89, 3.98)** 1.35 (0.83, 2.20)
Dyslipidemia 1.92 (1.36, 2.72)** 0.91 (0.58, 1.43) 1.92 (1.39, 2.66)** 0.86 (0.56, 1.33)
ischemic heart disease 4.10 (2.82, 5.96)** 2.72 (1.74, 4.26)** 12.2 (8.17, 18.1)** 11.4 (7.17, 18.2)**
Age (per 10 years) 0.79 (0.67, 0.92)** 1.43 (1.16, 1.77)** 1.31 (1.12, 1.53)** 0.68 (0.56, 0.83)**
Notes: 1Unadjusted odds ratios were calculated using the following method: OR, Odds of having lower extremity arterial disease in exposure group/Odds of having lower 
extremity arterial disease in nonexposure group; 2Adjusted odds ratios were obtained from a multivariate logistic regression model that included all variables in this table. 
*P , 0.05; **P , 0.01.
Abbreviations: ci, confidence intervals; OR, odds ratioVascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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study included a large number of subjects, this difference is 
difficult to ignore. The mechanism by which hypothyroidism 
may confer differential vascular risk by gender is unclear. 
In the United States, women tend to be screened and treated 
earlier for hypothyroidism than men.21 This could explain in 
part why hypothyroidism was associated with lower   extremity 
arterial disease in men, but not in women. Men may not be 
screened as early as women, and prolonged uncorrected 
hypothyroidism may lead to greater vascular risk. However, 
this phenomenon alone cannot fully explain our study results, 
as we found a negative association between hypothyroidism 
and lower extremity arterial disease in women. One explana-
tion might be that earlier identification of hypothyroidism in 
women leads to more aggressive and earlier modification of 
other vascular risk factors, but this is speculative and should 
be further evaluated in prospective studies.
In our study, both diabetes and hypertension were more 
strongly associated with lower extremity arterial disease in 
men than in women. A few previous studies have examined 
the gender-specific impact of risk factors on the development 
of cardiovascular diseases in men and women. In one large 
prospective cohort study of over 18,000 patients, the rela-
tive risk of myocardial infarction was higher in women with 
diabetes, hypertension, and left ventricular hypertrophy than 
in men with the same risk factors.22 Hypothyroidism was not 
examined as a risk factor in that study.
The strengths of our study are the large number of sub-
jects and the consistency of data collection methods and 
definitions between groups. Our study also has limitations. 
First, we were unable to accurately obtain data regarding 
tobacco use among subjects, because tobacco use data were 
not consistently found in the surgical preoperative history 
and anesthesia record. Second, because of the retrospective 
nature of our study and the fact that not all patients received 
primary care at our center, we do not have laboratory data 
to confirm medical diagnoses such as diabetes mellitus and 
dyslipidemia or to assess the adequacy of thyroid replacement 
in subjects with hypothyroidism. However, the objective of 
this study was to test the association between the diagnosis 
of hypothyroidism and lower extremity arterial disease 
regardless of adequate hormone replacement. It is possible 
that early and proper hormone replacement may decrease 
the risk of lower extremity arterial disease in patients with 
hypothyroidism, and this is an area that should be explored 
in future studies. Further, we used similar criteria to define 
diabetes mellitus and hypertension in our study, and data 
regarding duration of disease or adequacy of treatment were 
similarly lacking for these two conditions. Nevertheless, both 
  conditions were strongly associated with lower extremity 
arterial disease as expected. This is consistent with prior 
studies that have reported that these two conditions are two 
of the most important risk factors for peripheral vascular 
disease, thereby lending validity of the methods by which 
we defined disease states in our study.11
One final weakness that must be addressed is that there 
were significant differences in age between male cases and 
controls as well as between female cases and controls in the 
gender-stratified analyses. Specifically, among male subjects, 
cases were older than controls (mean age differed by approxi-
mately 3 years), whereas among female subjects, controls 
were older than cases (mean age differed by approximately 
3 years). This may have occurred, in part, because we age-
matched subjects prior to gender stratification. It is possible 
that the age difference between cases and controls could have 
biased our results to some degree because the prevalence of 
hypothyroidism increases with age. However, we controlled 
for age in the multivariate analysis and still found significant 
associations between hypothyroidism and lower extremity 
arterial disease for both genders.
Conclusion
Gender is a significant effect modifier for the association 
between hypothyroidism and lower extremity arterial disease. 
The association is positive in men and negative in women. 
Future prospective studies that evaluate hypothyroidism as 
a risk factor for peripheral arterial disease should consider 
gender stratification in order to corroborate this finding.
Disclosure
No competing financial interests exist.
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